Rhumbline Advisers cut its holdings in shares of Chimera Investment Co. (NYSE:CIM – Free Report) by 64.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 138,976 shares of the real estate investment trust’s stock after selling 252,626 shares during the period. Rhumbline Advisers owned about 0.17% of Chimera Investment worth $1,779,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of CIM. Strategic Advisors LLC lifted its position in shares of Chimera Investment by 14.2% during the first quarter. Strategic Advisors LLC now owns 20,155 shares of the real estate investment trust’s stock worth $93,000 after purchasing an additional 2,500 shares during the last quarter. Private Advisor Group LLC lifted its position in shares of Chimera Investment by 23.0% during the fourth quarter. Private Advisor Group LLC now owns 16,421 shares of the real estate investment trust’s stock worth $82,000 after purchasing an additional 3,066 shares during the last quarter. ProShare Advisors LLC lifted its position in shares of Chimera Investment by 8.5% during the first quarter. ProShare Advisors LLC now owns 40,895 shares of the real estate investment trust’s stock worth $189,000 after purchasing an additional 3,218 shares during the last quarter. Cape Investment Advisory Inc. bought a new position in shares of Chimera Investment during the fourth quarter worth about $27,000. Finally, Principal Securities Inc. bought a new position in shares of Chimera Investment during the fourth quarter worth about $28,000. 48.44% of the stock is currently owned by institutional investors and hedge funds.
Chimera Investment Stock Performance
Shares of NYSE CIM opened at $16.65 on Friday. The company has a quick ratio of 4.43, a current ratio of 4.43 and a debt-to-equity ratio of 3.75. The firm’s 50-day moving average price is $15.09 and its two-hundred day moving average price is $13.83. Chimera Investment Co. has a 52-week low of $11.28 and a 52-week high of $18.00. The stock has a market capitalization of $1.34 billion, a P/E ratio of 10.97 and a beta of 1.73.
Chimera Investment Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 31st. Investors of record on Monday, September 30th will be paid a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a dividend yield of 8.89%. The ex-dividend date is Monday, September 30th. This is a positive change from Chimera Investment’s previous quarterly dividend of $0.35. Chimera Investment’s dividend payout ratio (DPR) is currently 91.50%.
Analyst Upgrades and Downgrades
CIM has been the topic of several research analyst reports. StockNews.com cut shares of Chimera Investment from a “buy” rating to a “hold” rating in a research report on Thursday, August 15th. Keefe, Bruyette & Woods raised their target price on shares of Chimera Investment from $15.00 to $16.00 and gave the stock a “market perform” rating in a report on Thursday, August 8th.
Check Out Our Latest Analysis on Chimera Investment
About Chimera Investment
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.
Read More
- Five stocks we like better than Chimera Investment
- With Risk Tolerance, One Size Does Not Fit All
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- What is the Australian Securities Exchange (ASX)
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- How Can Investors Benefit From After-Hours Trading
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Chimera Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment and related companies with MarketBeat.com's FREE daily email newsletter.